Search - tctmd.com

Displaying 141 - 160 of 174

Sort: Relevancy | Date

News Conference News TCT 2015

Global TAVR Market Poised to Exceed DES Market by 2025

October 11, 2015

News Conference News TCT 2015

Asian TAVR Registry Shows Good Procedural and Clinical Results

October 11, 2015

News Features TCT 2014

Thoughtful Insights at TCT: Many Questions Remain Around Treatment of Valvular Disease

Todd Neale

October 24, 2014

News Conference News TCT 2014

First TCT Innovation Award Given for Novel Cooling System

September 16, 2014

News Conference News TCT 2014

New Devices May Help Overcome the Issue of Paravalvular Regurgitation After TAVR

September 15, 2014

News Conference News TCT 2014

Capture Devices Hold Promise for Decreasing TAVR-Related Stroke

September 15, 2014

News Conference News TCT 2014

TCT Course Director Outlines Current TAVR Controversies

September 14, 2014

News Conference News TCT 2014

Registry Data Show Promise of Valve-in-Valve TAVR in High-Risk Patients

September 14, 2014

News Conference News TCT 2014

PARTNER: Post-TAVR Survival Higher in Overweight, Obese Patients

September 14, 2014

News Conference News TCT 2014

Lively Debate on Use of TAVR for Lower-Risk Patients

September 14, 2014

Presentation TCT 2014

Case #3: A Patient with Heart Failure and Improving LV-EF After CCM

Presenter: Sigmund Silber, Vivek Y. Reddy

September 13, 2014

Presentation TCT 2014

Case #3: Cardiac Arrest Prior to PCI

Presenter: Ajay J. Kirtane, Ranjit Kumar Nath

September 13, 2014

Presentation TCT 2014

Updates from PARTNER 2A and Sapien 3 in Intermediate-Risk Patients

Presenter: Martin B. Leon, Neil E. Moat, Ariel Finkelstein, Vinod H. Thourani

September 13, 2014

Presentation TCT 2014

PARTNER I: Five-Year Results From a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement with a Balloon-Expandable Device Versus Conservative Care in Extremely High-Risk Patients with Aortic Stenosis

Presenter: Patrick W. Serruys, David J. Cohen, Samir R. Kapadia

September 13, 2014

News Conference News TCT 2014

PARTNER Shows Clear TAVR Benefit at 5 Years in Inoperable Patients

Yael L. Maxwell

September 13, 2014

News Conference News TCT 2013

Innovation in Intervention: Perspectives from Industry

October 30, 2013

News Conference News TCT 2013

Two Trials to Assess TAVR in Moderate-Risk Patients

October 30, 2013

News Conference News TCT 2013

Data Evolving for Pharmacological Treatment Strategies for Patients with AF and Valvular Heart Disease

October 29, 2013

Presentation TCT 2013

PARTNER: 3 Years Later, What Have We Learned?

Presenter: Raj Makkar

October 28, 2013

News Conference News TCT 2013

Long-Term Outcomes, Cost May Influence Use of TAVR in Moderate-Risk Patients

October 28, 2013

Advertisement

Global TAVR Market Poised to Exceed DES Market by 2025

Asian TAVR Registry Shows Good Procedural and Clinical Results

Thoughtful Insights at TCT: Many Questions Remain Around Treatment of Valvular Disease

First TCT Innovation Award Given for Novel Cooling System

New Devices May Help Overcome the Issue of Paravalvular Regurgitation After TAVR

Capture Devices Hold Promise for Decreasing TAVR-Related Stroke

TCT Course Director Outlines Current TAVR Controversies

Registry Data Show Promise of Valve-in-Valve TAVR in High-Risk Patients

PARTNER: Post-TAVR Survival Higher in Overweight, Obese Patients

Lively Debate on Use of TAVR for Lower-Risk Patients

Case #3: A Patient with Heart Failure and Improving LV-EF After CCM

Case #3: Cardiac Arrest Prior to PCI

Updates from PARTNER 2A and Sapien 3 in Intermediate-Risk Patients

PARTNER I: Five-Year Results From a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement with a Balloon-Expandable Device Versus Conservative Care in Extremely High-Risk Patients with Aortic Stenosis

PARTNER Shows Clear TAVR Benefit at 5 Years in Inoperable Patients

Innovation in Intervention: Perspectives from Industry

Two Trials to Assess TAVR in Moderate-Risk Patients

Data Evolving for Pharmacological Treatment Strategies for Patients with AF and Valvular Heart Disease

PARTNER: 3 Years Later, What Have We Learned?

Long-Term Outcomes, Cost May Influence Use of TAVR in Moderate-Risk Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content